Here we show that pharmacologic inhibition or genetic deletion of ACC1 significantly increases murine Treg suppressive function in vitro, and, as compared with wild-type (WT), ACC1KO Tregs had an enhanced ability to treat and prevent murine GVHD. The gene discussed is ACACA; the disease is graft versus host disease.